Mast To Develop Vepoloxamer (MST-188) In Chronic Heart Failure

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/2/2026

1. AMZN
2. RBLX
3. AAPL
4. RDDT
5. COIN
6. NBIX
7. DXCM
8. GH
9. GDDY
10. WU

Go back to Mast To Develop Vepoloxamer (MST-188) In Chronic Heart Failure
MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) Delayed: 8.04 -0.75 (8.53%)
Previous Close $8.79    52 Week High $0.71 
Open $8.33    52 Week Low $0.07 
Day High $8.36    P/E N/A 
Day Low $7.29    EPS $-0.35 
Volume 9,534,584       

MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) Delayed: 8.04 -0.75 (8.53%)
Previous Close $8.79    52 Week High $0.71 
Open $8.33    52 Week Low $0.07 
Day High $8.36    P/E N/A 
Day Low $7.29    EPS $-0.35 
Volume 9,534,584